Mar. 19 2024
Source Page: FOI responses published by MOD: week commencing 18 March 2024Found: Candidates with carcinoid tumours, thymic tumours and multiple adenomata are graded P8 because of the
Mar. 15 2024
Source Page: I. Equity in medical devices: Independent Review. Incl. appendices [Chair, Dame Margaret Whitehead]. 130p. II. Government response to the report of the equity in medical devices: independent review. 64p.Found: unnecessary treatment given to patients to improve the oxygen values derived from the spectroscopy, when brain
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023Found: n (%)Placebo N=966 n (%)Odds -ratioFTY720 N=107 n (%)IFNβ -1a N=107 n (%) Malignant or unspecified tumours
Mentions:
1: Wishart, Beatrice (LD - Shetland Islands) March is brain tumour awareness month. - Speech Link
2: Yousaf, Humza (SNP - Glasgow Pollok) tumours, the need to be cautious and the need to be conscious of getting support where necessary. - Speech Link
Mar. 11 2024
Source Page: Equity in medical devices: independent review - final reportFound: unnecessary treatment given to patients to improve the oxygen values derived from the spectroscopy, when brain
Mar. 11 2024
Source Page: Equity in medical devices: independent review - final reportFound: unnecessary treatment given to patients to improve the oxygen values derived from the spectroscopy, when brain
Asked by: Hamilton, Rachael (Scottish Conservative and Unionist Party - Ettrick, Roxburgh and Berwickshire)
Question
To ask the Scottish Government what recent steps have been taken to improve diagnosis times for those affected by brain tumours.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government published our ten year Cancer Strategy for Scotland 2023-2033 along with an initial three year Cancer Action Plan ( Cancer Plan for Scotland 2023 – 2026 ) in June 2023.
Over the next 10 years, our strategic aim is to improve cancer survival and provide excellent, equitably accessible care. The Strategy and Plan take a comprehensive approach to improving patient pathways from prevention and diagnosis through to treatment and post-treatment care. We continue to place an emphasis on the less survivable cancers, including brain cancer, and improving their outcomes.
As part of this strategy, we developed a new Earlier Cancer Diagnosis Vision.
The vision includes continuing to deliver our Detect Cancer Earlier Programme, working with primary care clinicians to ensure they have direct access to diagnostic tests and quality education sources, as well as developing public campaigns to educate and empower those with possible symptoms of cancer to act early.
In addition to this work and in order to support radiology diagnostic capacity, we have funded mobile scanners to provide additional capacity for MRI and CT supporting cancer patients across NHS Scotland.
Mentions:
1: Siobhain McDonagh (Lab - Mitcham and Morden) with brain tumours; to make provision in relation to neuro-oncology multidisciplinary teams in the NHS - Speech Link
A Bill to set a target for the number of glioblastoma patients who take part in clinical trials each year; to require training for medical oncologists to include training relating to brain cancers; to provide that any drug that has been licensed for use on tumours must be trialled on people with brain tumours; to make provision in relation to neuro-oncology multidisciplinary teams in the NHS, including a requirement that each such team must include a medical oncologist; to require manufacturers of drugs licensed to treat tumours to make those drugs available in specified circumstances for clinical trials relating to brain tumours; to make provision about the application of funding caps on funding for multi-drug treatments for glioblastoma brain tumours; to make provision about the processes for funding of drugs intended for the treatment of glioblastoma; to make provision about the management of drug trial data, for the purpose of increasing the quality of data relating to glioblastoma patients; to make provision about reviewing the allocation of existing funding for brain tumour research by the National Institute for Health and Care Research; to make provision about the direct referral of patients by optometrists to accident and emergency departments for the purpose of diagnosing brain tumours; and for connected purposes.